Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Begin retirement savings contributions as soon as you can. The earlier you start, the more time your money has to grow.
10,950 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Uber unveils a multiyear pact to invest up to $1.25 billion in Rivian, aiming to roll out up to 50,000 autonomous Riv...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
Young graduates facing scarce first jobs as data show the entry-level market worst it’s unfolding despite a steadier ...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...
Capital One’s stock sits near $184 after a wave of acquisitions and an earnings miss. Here’s what Wall Street expects...
A federal jury awarded $3 million to a woman in the first-ever social media addiction trial against Meta and Google, ...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Colombia unveils a bold plan to turn the Caribbean coast into a bitcoin mining hub powered by renewable energy, tying...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
A targeted Florida housing bill aims to convert idle Southeast Florida golf courses into housing, triggering lawsuits...